675
Views
20
CrossRef citations to date
0
Altmetric
Clinical Features

OxyContin® Abuse and Overdose

, BS, , MD, , PharmD & , DO, EMT-P, FACEP
Pages 163-167 | Published online: 13 Mar 2015

References

  • . OxyContin [package insert]. Stamford, CT: Purdue Pharma, LP; 2007. http://www.pharma.com/html/our_products/our_products.htm. Accessed September 12, 2008
  • . Trescot AM, Datta S, Lee M, Hansen H. Opioid pharmacology. Pain Physician. 2008;11( 2 suppl):S133–S153
  • . Gossop M, Griffiths P, Powis B, Strang J. Cocaine: patterns of use, route of administation, and severity of dependence. Br J Psychiatry. 1994;164(5):660–664
  • . Marsch LA, Bickel WF, Badger WJ,. Effects of infusion rate of intravenously administered morphine on physiological, pscyhomotor, and self-reported measures in humans. J Pharmacol Exp Ther. 2001;299(3):1056–1065
  • . Oldendorf WH. Some relationships between addiction and drug delivery to the brain. NIDA Res Monogr. 1992;120:13–25
  • . Roset PN, Farré M, de la Torre R,. Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy males. Drug Alcohol Depend. 2001;64(3):285–298
  • . Cicero TJ, Inciardi JA, Muñoz A. Trends in abuse of Oxycontin and other opioid analgesics in the United States: 2002–2004. J Pain. 2005;6(10):662–672
  • . Roche T. The potent perils of a miracle drug. Time. 2001;157(1):47
  • . Jayawant SS, Balkrishnan R. The controversy surrounding OxyContin abuse: issues and solutions. Ther Clin Risk Manag. 2005;1(2):77–82
  • . Suffett WL. OxyContin abuse. J Ky Med Assoc. 2001;99(2):72
  • . Tunnell KD. The OxyContin epidemic and crime panic in rural Kentucky. Contemporary Drug Problems. 2005;32(2):225
  • . US Department of Health and Human Services. CSAT Advisory. OxyContin: prescription drug abuse. April 1, 2001
  • . Katz DA, Hays LR. Adolescent OxyContin Abuse. J Am Acad Child Adolesc Psychiatry. 2004;43(2):231–234
  • . US Department of Justice, Drug Enforcement Administration. Office of Diversion Control. Drugs and chemicals of concern: summary of medical examiner reports on oxycodone-related deaths. http://www.deadiversion.usdoj.gov/drugs_concern/oxycodone/oxycontin7.htm. Published July 21, 2008. Accessed October 1, 2008
  • . Substance Abuse and Mental Health Services Administration. Drug Abuse Warning Network, 2005: national estimates of drug-related emergency department visits. DAWN Series D-29, 2007. Rockville, MD: SAMHSA; 2007
  • . Cone EJ, Frant RV, Rohay JM,. Oxycodone involvement in drug abuse deaths: a DAWN-based classification scheme applied to an oxycodone postmortem database containing over 1000 cases. J Anal Toxicol. 2003;27(2):57–67
  • . Drummer OH, Surkamem ML, Phelan M, Cordner SM. A study of deaths involving oxycodone. J Forensic Sci. 1994;39(4):1069–1075
  • . Substance Abuse and Mental Health Services Administration. The DAWN Report: oxycodone, hydrocodone, and polydrug use, 2002. Rockville, MD: SAMHSA; July 2004
  • . Arnold C. Teen abuse of painkiller OxyContin on the rise. All Things Considered. National Public Radio. 2005. http://www.npr.org/templates/story/story.php?storyId=5061674. Accessed October 1, 2008
  • . Goldfrank L, Flomenbaum NE, Lewin N,. Goldfrank's Toxicologic Emergencies. 8th ed. New York, NY: The McGraw-Hill Companies, Inc; 2006
  • . Schneir AB, Vadeboncoeur TF, Offerman SR,. Massive OxyContin ingestion refractory to naloxone therapy. Ann Emerg Med. 2002;40(4):425–28
  • . Weil JV, McCullough RE, Kline JS, Sodal IE. Diminished ventilatory response to hypoxia and hypercapnia after morphine in normal man. N Engl J Med. 1975;292(21):1103–1106
  • . Osler W. Oedema of left lung-Morphia poisoning. Montreal General Hospital Reports. Vol 1. Montreal, Canada: Dawson Bros Publishers; 1880:291–293
  • . Ward JM, McGrath RL, Weil JV. Effects of morphine on the peripheral vascular response to sympathetic stimulation. Am J Cardiol. 1972;29(5):659–666
  • . Fahmy NR, Sunder N, Soter NA. Role of histamine in the hemodynamic and plasma catecholamine responses to morphine. Clin Pharmacol Ther. 1983;33(5):615–620
  • . Barke KE, Hough LB. Opiates, mast cells and histamine release. Life Sci. 1993;53(18):1391–1399
  • . Lee HK, Wang SC. Mechanism of morphine-induced miosis in the dog. J Pharmacol Exp Ther. 1975;192(2):415–431
  • . Greene D. Total necrosis of the intranasal structures and soft palate as a result of nasal inhalation of crushed OxyContin. Ear Nose Throat Journal. 2005;84(8):512, 514, 516
  • . Davis MP, Varga J, Dickerson D,. Normal release and controlled release oxycodone: pharmacokinetics, pharmacodynamics and controversy. Support Care Cancer. 2003;11(2):84–92
  • . Bracken MB, Shepard MJ, Collins WF,. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. N Engl J Med. 1990;322(20):1405–1411
  • . Buajordet I, Naess AC, Jacobsen D, Brors D. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med. 2004;11(1):19–23

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.